Zoe K Price

6PUBLICATIONS
18CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 13, 2025
Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer.

Riya Khetan, Noor A Lokman, Preethi Eldi

|Jun 26, 2025
Identification of Proteins Associated with Ovarian Cancer Chemotherapy Resistance Using MALDI-MSI.

Tannith M Noye, Parul Mittal, Zoe K Price

|May 13, 2025
Identification of Sphingosine Kinase 1 as a Novel Protein Regulated by High Molecular Weight Hyaluronan in Ovarian Cancer.

Zoe K Price, Noor A Lokman, Jessica Morrison

|Jan 08, 2023
Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways.

Zoe K Price, Noor A Lokman, Masato Yoshihara

|Dec 06, 2018
Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance.

Zoe K Price, Noor A Lokman, Carmela Ricciardelli

Pageof 1